Early-Onset Colorectal Cancer Linked to Metabolic Disorders

Strategic Insights -

A new study published in the journal Nature Reviews Endocrinology has revealed a strong connection between early-onset colorectal cancer (EOCRC) and metabolic disorders, particularly obesity and type 2 diabetes mellitus (T2DM). The research, conducted by a team of scientists from Massachusetts General Hospital and Harvard Medical School, suggests that the alarming rise in EOCRC incidence since the 1990s is largely attributed to the increasing burden of metabolic diseases among young populations.

The study synthesizes evidence on the relationship between obesity, T2DM, and EOCRC, focusing on pathophysiological mechanisms and the mediating roles of diet and lifestyle factors. The authors highlight the need for clinical and public health strategies to address obesity and T2DM for EOCRC prevention, emphasizing knowledge gaps and future research directions.

Key Takeaways:

  • Early-onset colorectal cancer (EOCRC) is emerging as a pressing public health concern, with an alarming rise in incidence since the 1990s.
  • The burden of metabolic diseases, particularly obesity and type 2 diabetes mellitus (T2DM), has surged among young populations, coinciding with the increasing number of EOCRC cases.
  • The study has synthesized evidence on the relationship between obesity, T2DM, and EOCRC, highlighting the mediating roles of diet and lifestyle factors.
  • The authors emphasize the need for clinical and public health strategies to address obesity and T2DM for EOCRC prevention.
  • The study has identified knowledge gaps and future research directions in understanding the relationship between obesity, T2DM, and EOCRC.

Statistics:

  • The incidence of early-onset colorectal cancer (EOCRC) has risen significantly since the 1990s.
  • At least eight high-income countries have observed a rising trend in EOCRC incidence, with the USA being one of them.
  • The burden of metabolic diseases, such as obesity and T2DM, has surged among young populations, with obesity rates increasing by over 30% since the 1990s.
  • The median age of EOCRC diagnosis is under 50 years, which is lower than the median age for late-onset colorectal cancer (LCC).

Sources:

  • Early-onset colorectal cancer as an emerging disease of metabolic dysregulation. Nature Reviews Endocrinology, 2025;21(11):686-702. [1]
  • NewsRx. New Findings from Massachusetts General Hospital and Harvard Medical School in the Area of Emerging Diseases Reported (Early-onset colorectal cancer as an emerging disease of metabolic dysregulation). Obesity & Diabetes Week. October 20, 2025; p 66. [2]

[1] Nature Reviews Endocrinology. (2025). Early-onset colorectal cancer as an emerging disease of metabolic dysregulation. 21(11), 686-702.

[2] NewsRx. (2025). New Findings from Massachusetts General Hospital and Harvard Medical School in the Area of Emerging Diseases Reported (Early-onset colorectal cancer as an emerging disease of metabolic dysregulation). Obesity & Diabetes Week, 66.